Dr. Dongli Chen is the President and CSO of AA ( American Advanced ) Pharmaceuticals Inc and the CSO of Qinghai Renyi Pharmaceuticals . Both are drug discovery companies . He has more than 20 years experience at drug discovery , business development and management at Boston 128 high-tech area. His research fields include HIV , Alzheimer's disease , anxiety and depression , obesity , cognitive impairment associated with schizophrenia , pulmonary hypertension , autoimmune diseases , inflammatory disorders , cancer , cystic fibrosis and diabetes . He has more than 30 publications and more than 20 patents . He received the Green Chemistry President Award . Dr. Chen received his BS , MS and PhD from Zhengzhou University , Chinese Academy of Sciences and Boston College .